Italia markets close in 33 minutes

China Resources Beer (Holdings) Company Limited (0291.HK)

HKSE - HKSE Prezzo differito. Valuta in HKD.
Aggiungi a watchlist
57,5000,000 (0,00%)
Alla chiusura: 04:08PM HKT
Schermo intero
Chiusura precedente57,500
Aperto56,950
Denaro57,450 x 0
Lettera57,500 x 0
Min-Max giorno56,950 - 58,550
Intervallo di 52 settimane35,900 - 64,950
Volume4.559.041
Media Volume8.297.821
Capitalizzazione186,53B
Beta (5 anni mensile)0,61
Rapporto PE (ttm)39,38
EPS (ttm)1,460
Prossima data utili22 mar 2023 - 27 mar 2023
Rendimento e dividendo (forward)0,62 (1,07%)
Data ex dividendo30 ago 2022
Stima target 1A68,89
  • GlobeNewswire

    Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI)

    Company announcement – No. 4 / 2022 Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI) Top-line results expected in the second quarter of 2022Pending positive results, Zealand intends to file for marketing approval with the US Food and Drug Administration Copenhagen, DK and Boston, MA, U.S. February 15, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and